OHE Lunchtime Seminar with Pedro Pita Barros on ‘Incentives for R&D, Competition and Intertemporal Effects of Payment Rules for Cures’. To be held on 6 June 2019 from 12 p.m. to 2 p.m. Current payment and pricing rules for pharmaceutical… Read More »OHE Lunchtime Seminar: Incentives for R&D, Competition and Intertemporal Effects of Payment Rules for Cures
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Sam Watson’s journal round-up for 12th November 2018
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Chris Sampson’s journal round-up for 8th January 2018
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Sam Watson’s journal round-up for 11th December 2017
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Chris Sampson’s journal round-up for 14th August 2017
On the third Thursday of every month we speak to a recent graduate about their thesis and their studies. This month’s guest is Dr Thomas Allen who graduated with a PhD from the University of Manchester. If you would like… Read More »Thesis Thursday: Thomas Allen
The UN Secretary General’s High Level Panel on Access to Medicines recently published its long awaited report Promoting innovation and access to health technologies. The report explores and proposes some solutions to the well recognised problem of under-investment in research and… Read More »Access to medicines and medical technologies for the global poor
There is a considerable furore surrounding the new proposal to pay GPs £55 for each dementia diagnosis. The Patients Association called it “a step too far” that would mean a “bounty on the head” of some patients (link), while the… Read More »Is payment by diagnosis for dementia a good strategy?
Incentives are widely and frequently used to influence preferences among people with the aim of achieving some socially beneficial end. These incentives include fines, rewards, and taxes. From the domain of health, Pigouvian taxes on foods deemed unhealthy and pricing… Read More »Incentives and social preferences
What causes people to respond to incentives? From a simplistic view we may say that people just pick the option with the highest utility; everybody has a price, right? Financial incentives are often used to alter health related behaviours. In… Read More »The impact of incentives